| Dr Frederick Michael Elliott, MD | |
|
897 Delaware Ave Ste 205, Buffalo, NY 14209-2087 | |
| (716) 768-2006 | |
| (716) 768-2007 |
| Full Name | Dr Frederick Michael Elliott |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 23 Years |
| Location | 897 Delaware Ave Ste 205, Buffalo, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023080728 | NPI | - | NPPES |
| 02686419 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 236287 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erie County Medical Center | Buffalo, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Erie County Medical Center Corporation | 1456308907 | 207 |
| Horizon Health Services Inc | 5698689925 | 94 |
| Ub Family Medicine Inc | 1658361381 | 28 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
| Entity Name | Horizon Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043387152 PECOS PAC ID: 5698689925 Enrollment ID: O20031119000414 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
| Entity Name | Catholic Charities Of Buffalo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962596718 PECOS PAC ID: 0941196588 Enrollment ID: O20040304000485 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
| Entity Name | Ub Family Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942294467 PECOS PAC ID: 1658361381 Enrollment ID: O20040514000861 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
| Entity Name | Erie County Medical Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528233616 PECOS PAC ID: 1456308907 Enrollment ID: O20050715000538 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frederick Michael Elliott, MD 897 Delaware Ave Ste 205, Buffalo, NY 14209-2087 Ph: (716) 768-2006 | Dr Frederick Michael Elliott, MD 897 Delaware Ave Ste 205, Buffalo, NY 14209-2087 Ph: (716) 768-2006 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review Eisai's New Drug Application (NDA) for AcipHex Delayed-Release Sprinkle Capsules 5mg and 10mg for the proposed indication of healing of Gastroesophageal Reflux Disease (GERD), maintenance of healing of GERD and improvement of symptoms of GERD in children 1 to 11 years of age.
After years of research on cell surface receptors called Frizzleds, researchers at Karolinska Institutet in Sweden provide the proof-of-principle that these receptors are druggable by small molecules. The results, which are published in the scientific journal Nature Communications, open for new strategies to treat different types of cancer.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced today that Biocordcell Argentina S.A. (BioCells, Inc.) has launched a program to store dental pulp stem cells, the first stem cell storage bank in Argentina to offer this service.
› Verified 3 days ago
Dr. Robinder Bahniwal, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 34 Benwood Avenue, Buffalo, NY 14215 Phone: 716-986-9199 | |
Ashley L Wyant, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1021 Broadway St, Buffalo, NY 14212 Phone: 716-529-2030 | |
Maxiam Dean, Family Medicine Medicare: Medicare Enrolled Practice Location: 3495 Bailey Ave, Buffalo, NY 14215 Phone: 716-834-9200 | |
Douglas Howard Moffat, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 360 Forest Ave, Buffalo, NY 14213 Phone: 716-882-4900 Fax: 416-882-4426 | |
Dr. Michael Henry Kueker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 La Riviere Dr Ste 201, Buffalo, NY 14202 Phone: 716-893-1010 Fax: 716-893-1002 | |
Patricia A Pastore, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Niagara St, Niagara Family Health Center, Buffalo, NY 14201 Phone: 716-859-4110 Fax: 716-859-4179 | |
Jharna Basak, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 187 Cazenovia St, Buffalo, NY 14210 Phone: 716-823-3462 Fax: 716-823-9397 |